Calprotectin in Patients with Rheumatic Immunomediated Adverse Effects Induced by Checkpoints Inhibitors.

Cancers (Basel) · 2023 · PMC10251936 · PMID 37296947

Europe PMC DOI

hedged sentences

0.0500

closest p · 1.0× alpha

0.8000

boldest claim

The sentences

a statistical trendp < 0.05actually significant

Our findings showed a statistical trend toward higher levels of serum calprotectin in patients with inflammatory activity ( p < 0.05).

also in 493 other papers

did not reach statistical significancep value = 0.8not close (p > 0.1)

This difference did not reach statistical significance ( p value = 0.8).

also in 17,681 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.